المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Hematoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı., Ali, Rıdvan, Özkalemkaş, Fahir, Özkan, Atilla, Özçelik, Tülay, Özkocaman, Vildan, Akdağ, İbrahim, Ozan, Ülkü, AAG-8495-2021, AAH-1854-2021, 7201813027, 6601912387, 9250698600, 7005424333, 6603145040, 8342488100, 6507254632, 6602797853

مصطلحات موضوعية: Acute renal failure, Cancer, Imatinib, Leukemia, Tumour lysis syndrome, Humans, Antineoplastic agents, Kidney neoplasms, Middle Aged, myeloid, chronic, Kidney failure, acute, philadelphia-positive, Piperazines, Male, Protein-tyrosine kinases, Pyrimidines, Tumor lysis syndrome, Oncology, Hematology, Rasburicase, Hyperphosphatemia, Furosemide, Allopurinol, Asparaginase, Calcium, Creatinine, Cyclophosphamide, Daunorubicin

العلاقة: Makale - Uluslararası Hakemli Dergi; Leukemia Research; Ali, R. vd. (2007). "Tumour lysis syndrome with acute renal failure during imatinib therapy". Leukemia Research, 31(4), 573-574.; https://doi.org/10.1016/j.leukres.2006.05.005Test; https://www.sciencedirect.com/science/article/pii/S0145212606001639Test; http://hdl.handle.net/11452/28793Test; 000244826600025; 2-s2.0-33846702520; 573; 574; 31

الإتاحة: https://doi.org/10.1016/j.leukres.2006.05.005Test
http://hdl.handle.net/11452/28793Test
https://www.sciencedirect.com/science/article/pii/S0145212606001639Test

المؤلفون: Fahir Özkalemkaş, Tulay Ozcelik, Vildan Ozkocaman, Atilla Ozkan, Ahmet Tunali, Ülkü Ozan, Ibrahim Akdag, Rıdvan Ali

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Hematoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı., Ali, Rıdvan, Özkalemkaş, Fahir, Özkan, Atilla, Özçelik, Tülay, Özkocaman, Vildan, Akdağ, İbrahim, Ozan, Ülkü, AAG-8495-2021, AAH-1854-2021

مصطلحات موضوعية: Male, Cancer Research, Lysis, Letter, Imatinib therapy, Piperazines, Acute kidney failure, Tumour lysis syndrome, Acute renal failure, Furosemide, Antineoplastic agents, Hydroxyurea, Urea, Pallor, Treatment outcome, Fatigue, Cancer, Priority journal, Drug withdrawal, Leukemia, Dehydration, Chronic myeloid leukemia, Phosphorus, Hematology, Middle Aged, Protein-tyrosine kinases, Oncology, Vincristine, Creatinine, Retreatment, medicine.drug, Human, Adult, Allopurinol, Prednisolone, Leukemia, myeloid, chronic, Case report, medicine, Humans, Asparaginase, Petechia, Hemoglobin, Tumor lysis syndrome, Cyclophosphamide, Purpura, Tumor Lysis Syndrome, Rasburicase, Hyperphosphatemia, business.industry, Kidney failure, acute, Daunorubicin, Imatinib, medicine.disease, Cancer combination chemotherapy, Drug effect, Pyrimidines, Dyspnea, Cancer research, Potassium, Calcium, business, Kidney neoplasms, Leukemia, myeloid, philadelphia-positive, Diuretic agent, Rare disease, Uric acid

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a25f11ccc4a2e0b0fd9c9f8b59b39b1Test
http://hdl.handle.net/11452/28793Test